Folger Nolan Fleming Douglas Capital Management, Inc Abbott Laboratories Transaction History

Folger Nolan Fleming Douglas Capital Management, Inc

  • $915 Million
  • Q3 2024

A detailed history of Folger Nolan Fleming Douglas Capital Management, Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Folger Nolan Fleming Douglas Capital Management, Inc holds 101,418 shares of ABT stock, worth $11.5 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares
101,418
Previous 101,188 0.23%
Holding current value
$11.5 Million
Previous $10.5 Million 9.97%
% of portfolio
1.26%
Previous 1.18%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024
BUY
$100.07 - $118.13 $23,016 - $27,169
230 Added 0.23%
101,418 $11.6 Million
Q2 2024

Jul 09, 2024
SELL
$100.73 - $112.44 $196,222 - $219,033
-1,948 Reduced 1.89%
101,188 $10.5 Million
Q1 2024

Apr 12, 2024
BUY
$109.52 - $120.96 $649,563 - $717,413
5,931 Added 6.1%
103,136 $11.7 Million
Q4 2023

Feb 05, 2024
SELL
$90.19 - $110.4 $76,751 - $93,950
-851 Reduced 0.87%
97,205 $10.7 Million
Q3 2023

Oct 25, 2023
SELL
$95.53 - $114.62 $5,158 - $6,189
-54 Reduced 0.06%
98,056 $9.5 Million
Q2 2023

Jul 27, 2023
BUY
$100.78 - $112.29 $311,410 - $346,976
3,090 Added 3.25%
98,110 $10.7 Million
Q1 2023

Apr 28, 2023
SELL
$96.86 - $114.01 $58,309 - $68,634
-602 Reduced 0.63%
95,020 $9.62 Million
Q4 2022

Jan 30, 2023
BUY
$95.06 - $111.52 $399,347 - $468,495
4,201 Added 4.6%
95,622 $10.5 Million
Q3 2022

Nov 01, 2022
BUY
$96.76 - $112.03 $95,502 - $110,573
987 Added 1.09%
91,421 $8.85 Million
Q2 2022

Jul 15, 2022
BUY
$102.07 - $123.37 $12,656 - $15,297
124 Added 0.14%
90,434 $9.83 Million
Q1 2022

Apr 27, 2022
BUY
$114.02 - $139.04 $123,141 - $150,163
1,080 Added 1.21%
90,310 $10.7 Million
Q4 2021

Feb 01, 2022
SELL
$115.53 - $141.46 $95,774 - $117,270
-829 Reduced 0.92%
89,230 $12.6 Million
Q3 2021

Oct 29, 2021
BUY
$116.66 - $129.06 $238,336 - $263,669
2,043 Added 2.32%
90,059 $10.6 Million
Q2 2021

Aug 09, 2021
SELL
$105.79 - $124.53 $156,463 - $184,179
-1,479 Reduced 1.65%
88,016 $10.2 Million
Q1 2021

May 11, 2021
BUY
$108.84 - $128.23 $58,555 - $68,987
538 Added 0.6%
89,495 $10.7 Million
Q4 2020

Feb 05, 2021
SELL
$105.0 - $114.42 $109,935 - $119,797
-1,047 Reduced 1.16%
88,957 $9.74 Million
Q3 2020

Nov 12, 2020
BUY
$91.64 - $111.29 $43,529 - $52,862
475 Added 0.53%
90,004 $9.8 Million
Q2 2020

Aug 05, 2020
SELL
$76.57 - $98.0 $72,052 - $92,218
-941 Reduced 1.04%
89,529 $8.19 Million
Q1 2020

May 06, 2020
SELL
$62.82 - $91.86 $151,270 - $221,198
-2,408 Reduced 2.59%
90,470 $7.14 Million
Q4 2019

Feb 12, 2020
SELL
$78.51 - $87.4 $34,936 - $38,893
-445 Reduced 0.48%
92,878 $8.07 Million
Q3 2019

Nov 08, 2019
SELL
$81.84 - $88.74 $333,661 - $361,792
-4,077 Reduced 4.19%
93,323 $7.81 Million
Q2 2019

Aug 09, 2019
SELL
$72.88 - $85.0 $18,365 - $21,420
-252 Reduced 0.26%
97,400 $8.19 Million
Q1 2019

May 07, 2019
SELL
$66.22 - $80.06 $32,116 - $38,829
-485 Reduced 0.49%
97,652 $7.81 Million
Q4 2018

Feb 12, 2019
BUY
$65.56 - $74.27 $5.97 Million - $6.76 Million
91,039 Added 1282.6%
98,137 $7.1 Million
Q4 2018

Feb 11, 2019
SELL
$65.56 - $74.27 $5.94 Million - $6.73 Million
-90,612 Reduced 92.74%
7,098 $7.1 Million
Q3 2018

Nov 07, 2018
BUY
$60.81 - $73.36 $124,782 - $150,534
2,052 Added 2.15%
97,710 $7.17 Million
Q2 2018

Aug 08, 2018
BUY
$57.57 - $63.54 $17,558 - $19,379
305 Added 0.32%
95,658 $5.83 Million
Q1 2018

May 07, 2018
SELL
$56.27 - $63.62 $47,998 - $54,267
-853 Reduced 0.89%
95,353 $5.71 Million
Q4 2017

Feb 12, 2018
SELL
$53.68 - $57.47 $250,148 - $267,810
-4,660 Reduced 4.62%
96,206 $5.49 Million
Q3 2017

Nov 09, 2017
SELL
$48.06 - $53.64 $6,007 - $6,705
-125 Reduced 0.12%
100,866 $5.38 Million
Q2 2017

Aug 11, 2017
BUY
N/A
100,991
100,991 $4.91 Million

Others Institutions Holding ABT

# of Institutions
3,161
Shares Held
1.33B
Call Options Held
8.63M
Put Options Held
7.19M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Folger Nolan Fleming Douglas Capital Management, Inc Portfolio

Follow Folger Nolan Fleming Douglas Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Folger Nolan Fleming Douglas Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Folger Nolan Fleming Douglas Capital Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email